{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T21:46:03Z","timestamp":1792532763567,"version":"4.5.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T00:00:00Z","timestamp":1700179200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100018693","name":"Horizon 2020","doi-asserted-by":"publisher","award":["965196"],"award-info":[{"award-number":["965196"]}],"id":[{"id":"10.13039\/100018693","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018693","name":"Horizon 2020","doi-asserted-by":"publisher","award":["PMP21\/00052"],"award-info":[{"award-number":["PMP21\/00052"]}],"id":[{"id":"10.13039\/100018693","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI21\/00347"],"award-info":[{"award-number":["PI21\/00347"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PT20\/00109"],"award-info":[{"award-number":["PT20\/00109"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["DTS21\/00080"],"award-info":[{"award-number":["DTS21\/00080"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["AC22\/00009"],"award-info":[{"award-number":["AC22\/00009"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Espa\u00f1a Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["FPU18\/03189"],"award-info":[{"award-number":["FPU18\/03189"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Espa\u00f1a Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["PID2020-116709RB-I00"],"award-info":[{"award-number":["PID2020-116709RB-I00"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007801","name":"Fundaci\u00f3n S\u00e9neca","doi-asserted-by":"publisher","award":["21897\/PI\/22"],"award-info":[{"award-number":["21897\/PI\/22"]}],"id":[{"id":"10.13039\/100007801","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007801","name":"Fundaci\u00f3n S\u00e9neca","doi-asserted-by":"publisher","award":["20859\/PI\/18"],"award-info":[{"award-number":["20859\/PI\/18"]}],"id":[{"id":"10.13039\/100007801","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007801","name":"Fundaci\u00f3n S\u00e9neca","doi-asserted-by":"publisher","award":["21081\/PDC\/19"],"award-info":[{"award-number":["21081\/PDC\/19"]}],"id":[{"id":"10.13039\/100007801","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["PI21\/00347"],"award-info":[{"award-number":["PI21\/00347"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["21214\/FPI\/19"],"award-info":[{"award-number":["21214\/FPI\/19"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.xcrm.2023.101329","type":"journal-article","created":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T10:45:35Z","timestamp":1702982735000},"page":"101329","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["NLRP3 inflammasome activation and symptom burden in KRAS-mutated CMML patients is reverted by IL-1 blocking therapy"],"prefix":"10.1016","volume":"4","author":[{"given":"Laura","family":"Hurtado-Navarro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernesto Jos\u00e9","family":"Cuenca-Zamora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lurdes","family":"Zamora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Bellosillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esperanza","family":"Such","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Soler-Espejo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helios","family":"Mart\u00ednez-Banaclocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas M.","family":"Hern\u00e1ndez-Rivas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Marco-Ayala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Mart\u00ednez-Alarc\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lola","family":"Linares-Latorre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Garc\u00eda-\u00c1vila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Amat-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montserrat","family":"Arnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Pomares-Mar\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gonzalo","family":"Carre\u00f1o-Tarragona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzu Hua","family":"Chen-Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda T.","family":"Herranz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Garc\u00eda-Palenciano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Luz","family":"Morales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9s","family":"Jerez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda L.","family":"Lozano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ra\u00fal","family":"Teruel-Montoya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9688-1804","authenticated-orcid":false,"given":"Pablo","family":"Pelegr\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisca","family":"Ferrer-Mar\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2023.101329_bib1","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1182\/blood.2022015850","article-title":"International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data","volume":"140","author":"Arber","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2023.101329_bib2","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic\/Dendritic Neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.xcrm.2023.101329_bib3","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.3324\/haematol.2009.014001","article-title":"Molecular basis of myelodysplastic\/myeloproliferative neoplasms","volume":"94","author":"Reiter","year":"2009","journal-title":"Haematologica"},{"key":"10.1016\/j.xcrm.2023.101329_bib4","doi-asserted-by":"crossref","first-page":"3858","DOI":"10.1200\/JCO.2009.27.1361","article-title":"Next-Generation Sequencing Technology Reveals a Characteristic Pattern of Molecular Mutations in 72.8% of Chronic Myelomonocytic Leukemia by Detecting Frequent Alterations in TET2 , CBL , RAS , and RUNX1","volume":"28","author":"Kohlmann","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.xcrm.2023.101329_bib5","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1038\/s41467-021-23186-w","article-title":"RAS mutations drive proliferative chronic myelomonocytic leukemia via a KMT2A-PLK1 axis","volume":"12","author":"Carr","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2023.101329_bib6","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1200\/JCO.2012.47.3314","article-title":"Prognostic Score Including Gene Mutations in Chronic Myelomonocytic Leukemia","volume":"31","author":"Itzykson","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.xcrm.2023.101329_bib7","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1182\/blood-2012-08-452938","article-title":"Development and validation of a prognostic scoring system for patients with chronic myelomonocytic leukemia","volume":"121","author":"Such","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2023.101329_bib8","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.bbamcr.2006.10.001","article-title":"Roles of the Raf\/MEK\/ERK pathway in cell growth, malignant transformation and drug resistance","volume":"1773","author":"McCubrey","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.xcrm.2023.101329_bib9","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1038\/s41467-020-15497-1","article-title":"Oncogenic KrasG12D causes myeloproliferation via NLRP3 inflammasome activation","volume":"11","author":"Hamarsheh","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2023.101329_bib10","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/s41577-019-0228-2","article-title":"The gasdermins, a protein family executing cell death and inflammation","volume":"20","author":"Broz","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.xcrm.2023.101329_bib11","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/ni.2919","article-title":"The NLRP3 inflammasome is released as a particulate danger signal that amplifies the inflammatory response","volume":"15","author":"Baroja-Mazo","year":"2014","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.xcrm.2023.101329_bib12","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/ni.2913","article-title":"The adaptor ASC has extracellular and \u201cprionoid\u201d activities that propagate inflammation","volume":"15","author":"Franklin","year":"2014","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.xcrm.2023.101329_bib13","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202115415","article-title":"Nanobodies dismantle post-pyroptotic ASC specks and counteract inflammation in vivo","volume":"14","author":"Bertheloot","year":"2022","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.xcrm.2023.101329_bib14","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.immuni.2016.08.010","article-title":"K + Efflux-Independent NLRP3 Inflammasome Activation by Small Molecules Targeting Mitochondria","volume":"45","author":"Gro\u00df","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.xcrm.2023.101329_bib15","doi-asserted-by":"crossref","first-page":"4468","DOI":"10.1126\/sciadv.abf4468","article-title":"Sensing low intracellular potassium by NLRP3 results in a stable open structure that promotes inflammasome activation","volume":"7","author":"Tapia-Abell\u00e1n","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.xcrm.2023.101329_bib16","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.tips.2022.04.003","article-title":"NLRP3 and pyroptosis blockers for treating inflammatory diseases","volume":"43","author":"Coll","year":"2022","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.xcrm.2023.101329_bib17","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.3390\/diagnostics11111982","article-title":"From Immune Dysregulations to Therapeutic Perspectives in Myelodysplastic Syndromes: A Review","volume":"11","author":"Comont","year":"2021","journal-title":"Diagnostics"},{"key":"10.1016\/j.xcrm.2023.101329_bib18","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1182\/blood-2018-10-844654","article-title":"The central role of inflammatory signaling in the pathogenesis of myelodysplastic syndromes","volume":"133","author":"Sallman","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2023.101329_bib19","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1182\/blood.2021015173","article-title":"Role of allogeneic transplantation in chronic myelomonocytic leukemia: an international collaborative analysis","volume":"140","author":"Robin","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2023.101329_bib20","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1182\/blood-2016-06-724500","article-title":"Allogeneic hematopoietic stem cell transplantation for MDS and CMML: recommendations from an international expert panel","volume":"129","author":"de Witte","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2023.101329_bib21","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1002\/ajh.25104","article-title":"Chronic myelomonocytic leukemia: 2018 update on diagnosis, risk stratification and management","volume":"93","author":"Patnaik","year":"2018","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.xcrm.2023.101329_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.beha.2021.101244","article-title":"Novel therapeutic targets for chronic myelomonocytic leukemia","volume":"34","author":"Lasho","year":"2021","journal-title":"Best Pract. Res. Clin. Haematol."},{"key":"10.1016\/j.xcrm.2023.101329_bib23","doi-asserted-by":"crossref","first-page":"S337","DOI":"10.1016\/S2152-2650(21)01788-2","article-title":"MDS-029: Prevalence of VEXAS Syndrome in MDS\/CMML Patients with Systemic Inflammatory and Auto-Immune Disease","volume":"21","author":"Zhao","year":"2021","journal-title":"Clin. Lymphoma, Myeloma & Leukemia"},{"key":"10.1016\/j.xcrm.2023.101329_bib24","doi-asserted-by":"crossref","first-page":"455","DOI":"10.4049\/jimmunol.1401110","article-title":"A Novel Flow Cytometric Method To Assess Inflammasome Formation","volume":"194","author":"Sester","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.xcrm.2023.101329_bib25","series-title":"The Inflammasome. Methods in Molecular Biology1-9","article-title":"Assessment of ASC Oligomerization by Flow Cytometry","author":"Hurtado-Navarro","year":"2022"},{"key":"10.1016\/j.xcrm.2023.101329_bib26","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/s41586-022-04467-w","article-title":"Structure of the NLRP3 decamer bound to the cytokine release inhibitor CRID3","volume":"604","author":"Hochheiser","year":"2022","journal-title":"Nature (London, U. K.)"},{"key":"10.1016\/j.xcrm.2023.101329_bib27","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1038\/leu.2016.235","article-title":"Chronic myelomonocytic leukemia patients with RAS pathway mutations show high in vitro myeloid colony formation in the absence of exogenous growth factors","volume":"30","author":"Geissler","year":"2016","journal-title":"Leukemia"},{"key":"10.1016\/j.xcrm.2023.101329_bib28","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1182\/blood.2020008729","article-title":"Cytokine-like protein 1-induced survival of monocytes suggests a combined strategy targeting MCL1 and MAPK in CMML","volume":"137","author":"Sevin","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2023.101329_bib29","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1182\/bloodadvances.2019000585","article-title":"The transcriptome of CMML monocytes is highly inflammatory and reflects leukemia-specific and age-related alterations","volume":"3","author":"Franzini","year":"2019","journal-title":"Blood Adv."},{"key":"10.1016\/j.xcrm.2023.101329_bib30","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.immuni.2017.11.013","article-title":"The Pore-Forming Protein Gasdermin D Regulates Interleukin-1 Secretion from Living Macrophages","volume":"48","author":"Evavold","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.xcrm.2023.101329_bib31","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1126\/science.aaf3036","article-title":"An endogenous caspase-11 ligand elicits interleukin-1 release from living dendritic cells","volume":"352","author":"Zanoni","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2023.101329_bib32","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aav1447","article-title":"Gasdermin D activity in inflammation and host defense","volume":"4","author":"Lieberman","year":"2019","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.xcrm.2023.101329_bib33","doi-asserted-by":"crossref","DOI":"10.1097\/HS9.0000000000000150","article-title":"Diagnosis and Treatment of Chronic Myelomonocytic Leukemias in Adults","volume":"2","author":"Itzykson","year":"2018","journal-title":"Hemasphere"},{"key":"10.1016\/j.xcrm.2023.101329_bib34","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1182\/hematology.2020000163","article-title":"Evidence-Based Minireview: Myelodysplastic syndrome\/myeloproliferative neoplasm overlap syndromes: a focused review","volume":"2020","author":"Patnaik","year":"2020","journal-title":"Hematology"},{"key":"10.1016\/j.xcrm.2023.101329_bib35","doi-asserted-by":"crossref","first-page":"12981","DOI":"10.1074\/jbc.M117.778886","article-title":"The small GTPases K-Ras, N-Ras, and H-Ras have distinct biochemical properties determined by allosteric effects","volume":"292","author":"Johnson","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.xcrm.2023.101329_bib36","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.csbj.2019.12.004","article-title":"The current understanding of KRAS protein structure and dynamics","volume":"18","author":"Pantsar","year":"2020","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.xcrm.2023.101329_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2020.100652","article-title":"After 95 years, it\u2019s time to eRASe JMML","volume":"43","author":"Meynier","year":"2020","journal-title":"Blood Rev."},{"key":"10.1016\/j.xcrm.2023.101329_bib38","doi-asserted-by":"crossref","first-page":"14843","DOI":"10.1074\/jbc.270.25.14843","article-title":"How MAP Kinases Are Regulated","volume":"270","author":"Cobb","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.xcrm.2023.101329_bib39","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.1182\/blood-2016-07-730556","article-title":"The NLRP3 inflammasome functions as a driver of the myelodysplastic syndrome phenotype","volume":"128","author":"Basiorka","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2023.101329_bib40","doi-asserted-by":"crossref","first-page":"e393","DOI":"10.1016\/S2352-3026(18)30109-1","article-title":"Assessment of ASC specks as a putative biomarker of pyroptosis in myelodysplastic syndromes: an observational cohort study","volume":"5","author":"Basiorka","year":"2018","journal-title":"Lancet. Haematol."},{"key":"10.1016\/j.xcrm.2023.101329_bib41","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/nrd.2018.97","article-title":"Targeting the NLRP3 inflammasome in inflammatory diseases","volume":"17","author":"Mangan","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.xcrm.2023.101329_bib42","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1084\/jem.20151790","article-title":"A single domain antibody fragment that recognizes the adaptor ASC defines the role of ASC domains in inflammasome assembly","volume":"213","author":"Schmidt","year":"2016","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.xcrm.2023.101329_bib43","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/nsmb.3199","article-title":"Molecular basis of caspase-1 polymerization and its inhibition by a new capping mechanism","volume":"23","author":"Lu","year":"2016","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.xcrm.2023.101329_bib44","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1002\/art.39770","article-title":"Brief Report: Late-Onset Cryopyrin-Associated Periodic Syndrome Due to Myeloid-Restricted Somatic NLRP3 Mosaicism","volume":"68","author":"Mensa-Vilaro","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.xcrm.2023.101329_bib45","doi-asserted-by":"crossref","first-page":"e299","DOI":"10.1093\/rheumatology\/keac273","article-title":"Effective ex vivo inhibition of cryopyrin-associated periodic syndrome (CAPS)-associated mutant NLRP3 inflammasome by MCC950\/CRID3","volume":"61","author":"Weber","year":"2022","journal-title":"Rheumatology"},{"key":"10.1016\/j.xcrm.2023.101329_bib46","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/s41589-019-0278-6","article-title":"MCC950 closes the active conformation of NLRP3 to an inactive state","volume":"15","author":"Tapia-Abell\u00e1n","year":"2019","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.xcrm.2023.101329_bib47","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nm.3806","article-title":"A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases","volume":"21","author":"Coll","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2023.101329_bib48","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/s41589-019-0277-7","article-title":"MCC950 directly targets the NLRP3 ATP-hydrolysis motif for inflammasome inhibition","volume":"15","author":"Coll","year":"2019","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.xcrm.2023.101329_bib49","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.3389\/fimmu.2022.894470","article-title":"Soluble P2X7 Receptor Is Elevated in the Plasma of COVID-19 Patients and Correlates With Disease Severity","volume":"13","author":"Garc\u00eda-Villalba","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2023.101329_bib50","first-page":"299","article-title":"Evidence of inflammasome activation and formation of monocyte-derived ASC specks in HIV-1 positive patients","volume":"32","author":"Ahmad","year":"2018","journal-title":"AIDS (Phila.)"},{"key":"10.1016\/j.xcrm.2023.101329_bib51","doi-asserted-by":"crossref","DOI":"10.1038\/srep22586","article-title":"Macrophage activation and polarization modify P2X7 receptor secretome influencing the inflammatory process","volume":"6","author":"de Torre-Minguela","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.xcrm.2023.101329_bib52","doi-asserted-by":"crossref","first-page":"5439","DOI":"10.1038\/s41467-020-19288-6","article-title":"Immune modulatory effects of oncogenic KRAS in cancer","volume":"11","author":"Hamarsheh","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2023.101329_bib53","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/s41375-018-0203-0","article-title":"Heterogeneous expression of cytokines accounts for clinical diversity and refines prognostication in CMML","volume":"33","author":"Niyongere","year":"2019","journal-title":"Leukemia"},{"key":"10.1016\/j.xcrm.2023.101329_bib54","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/nrd3800","article-title":"Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases","volume":"11","author":"Dinarello","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.xcrm.2023.101329_bib55","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/s41467-022-35700-9","article-title":"Endogenous IL-1 receptor antagonist restricts healthy and malignant myeloproliferation","volume":"14","author":"Villatoro","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2023.101329_bib56","doi-asserted-by":"crossref","first-page":"E2797","DOI":"10.1073\/pnas.1402159111","article-title":"Activation of Ras overcomes B-cell tolerance to promote differentiation of autoreactive B cells and production of autoantibodies","volume":"111","author":"Teodorovic","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2023.101329_bib57","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/imr.12720","article-title":"FAS and RAS related Apoptosis defects: From autoimmunity to leukemia","volume":"287","author":"Meynier","year":"2019","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.xcrm.2023.101329_bib58","doi-asserted-by":"crossref","first-page":"580","DOI":"10.4049\/jimmunol.2200412","article-title":"Increased Inflammasome Activation Is Associated with Aging and Chronic Myelomonocytic Leukemia Disease Severity","volume":"210","author":"Andina","year":"2023","journal-title":"J. Immunol."}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379123005463?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379123005463?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T08:15:28Z","timestamp":1778919328000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379123005463"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":58,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S2666379123005463"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2023.101329","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NLRP3 inflammasome activation and symptom burden in KRAS-mutated CMML patients is reverted by IL-1 blocking therapy","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2023.101329","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors.","name":"copyright","label":"Copyright"}],"article-number":"101329"}}